Recombinant Acinetobacter baumannii UPF0060 membrane protein ACICU_02019 is a genetically engineered protein derived from the bacterium Acinetobacter baumannii. This protein is expressed in Escherichia coli and is often used in research settings for studying bacterial membrane functions and interactions. The protein is typically His-tagged, facilitating purification and detection in various biochemical assays.
Source: The protein is derived from Acinetobacter baumannii, a Gram-negative bacterium known for its role in nosocomial infections.
Expression Host: It is expressed in Escherichia coli, a common host for recombinant protein production due to its well-understood genetics and ease of manipulation.
Tag: The protein is His-tagged, which allows for efficient purification using nickel affinity chromatography.
Length: The full-length protein consists of 107 amino acids.
| Characteristic | Description |
|---|---|
| Source | Acinetobacter baumannii |
| Expression Host | Escherichia coli |
| Tag | His-tagged |
| Length | 107 amino acids |
Outer Membrane Vesicles (OMVs): A. baumannii secretes OMVs that contain virulence factors like outer membrane protein A (AbOmpA), which is cytotoxic to host cells .
Membrane Proteins: These proteins play crucial roles in bacterial survival and interaction with the host environment. Changes in membrane protein expression can affect bacterial resistance to antibiotics .
Pathogenesis Studies: Investigating how ACICU_02019 interacts with other membrane proteins could provide insights into A. baumannii's pathogenic mechanisms.
Drug Development: Understanding the roles of membrane proteins in drug resistance could lead to novel therapeutic strategies against A. baumannii infections.
KEGG: abc:ACICU_02019
The UPF0060 membrane protein family represents a group of uncharacterized membrane proteins found in various bacterial species including Acinetobacter baumannii. These proteins are characterized by their alpha-helical transmembrane domains and relatively small size. For example, the A1S_1909 protein, which is a UPF0060 family member in A. baumannii, consists of 107 amino acids with predicted transmembrane segments . These proteins are integral to the bacterial membrane and may play important roles in membrane organization, transport processes, or cell envelope integrity. Current research indicates that these proteins are highly conserved across different strains of A. baumannii, suggesting functional importance despite their uncharacterized status.
For optimal stability and activity, recombinant UPF0060 membrane proteins should be stored according to the following protocol:
Upon receipt, briefly centrifuge the vial to bring contents to the bottom
Reconstitute the lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (50% is recommended)
Aliquot for long-term storage at -20°C/-80°C
Avoid repeated freeze-thaw cycles as this significantly degrades membrane proteins
For working aliquots, store at 4°C for no more than one week
These storage conditions maintain protein integrity by preventing denaturation and aggregation that commonly affect membrane proteins. The addition of glycerol serves as a cryoprotectant, while aliquoting minimizes freeze-thaw damage. For experiments requiring active protein, always use freshly thawed aliquots rather than repeatedly freezing and thawing the same sample.
E. coli expression systems have proven effective for producing recombinant A. baumannii UPF0060 membrane proteins with high yield and purity. The following methodological approach is recommended:
Expression System Protocol:
Clone the target gene (e.g., A1S_1909) into an expression vector containing an N-terminal His-tag
Transform into an E. coli strain optimized for membrane protein expression (e.g., C41(DE3) or C43(DE3))
Grow cultures at lower temperatures (16-25°C) after induction to slow protein production and allow proper membrane insertion
Use mild detergents (DDM, LDAO) for membrane solubilization
Purify using nickel affinity chromatography followed by size exclusion chromatography
This approach yields proteins with >90% purity as determined by SDS-PAGE . The E. coli system is preferred because its membrane protein biogenesis machinery can accommodate heterologous membrane proteins through the action of SecY and Oxa1 family insertases, which are responsible for the insertion of transmembrane domains flanked by short translocated segments .
Verifying proper membrane insertion and folding of recombinant UPF0060 proteins requires multiple complementary approaches:
Experimental Verification Methods:
Protease Protection Assays
Expose membrane preparations to proteases (e.g., trypsin)
Analyze protease-resistant fragments by Western blotting
Properly inserted domains within the membrane will be protected from proteolysis
Circular Dichroism (CD) Spectroscopy
Measure in the far-UV range (190-260 nm)
Alpha-helical content should show characteristic minima at 208 and 222 nm
Compare experimental spectra with predicted secondary structure content
Fluorescence-Based Folding Assays
Incorporate environment-sensitive fluorescent probes
Monitor emission shifts that occur upon membrane insertion
Compare with denatured controls to confirm native folding
Sucrose Gradient Ultracentrifugation
Fractionate membrane preparations to confirm protein localization
Properly folded membrane proteins will co-migrate with membrane fractions
These methods collectively provide strong evidence for proper membrane localization and folding, addressing a critical concern in membrane protein studies where misfolding is common and can lead to misleading experimental results.
When investigating protein-lipid interactions of UPF0060 membrane proteins, researchers should employ these methodological approaches:
Protein-Lipid Interaction Analysis Protocol:
Lipid Reconstitution Studies
Reconstitute purified protein into liposomes of defined composition
Measure protein activity/stability in different lipid environments
Systematic variation of lipid headgroups and acyl chains can reveal specific requirements
Molecular Dynamics Simulations
Build models of UPF0060 proteins in membrane environments
Simulate protein behavior in different lipid compositions over nanosecond to microsecond timescales
Analyze protein-lipid contacts and bilayer deformations
Fluorescence Resonance Energy Transfer (FRET)
Label protein and specific lipids with FRET pairs
Measure energy transfer as indicator of proximity
Determine preferential interactions with specific lipid types
Native Mass Spectrometry
Use specialized MS conditions to preserve protein-lipid interactions
Identify co-purifying lipids that may be functionally important
Quantify binding affinities for different lipid species
These approaches provide complementary data on how UPF0060 membrane proteins interact with their lipid environment, which is crucial for understanding their in vivo function and stability.
Despite being conserved in A. baumannii strains, the precise biological function of UPF0060 membrane proteins remains incompletely characterized. Current research suggests several possible roles:
These proteins may contribute to membrane organization and integrity based on their predicted multiple transmembrane domains.
Sequence analysis reveals potential amphipathic regions that might function in membrane curvature sensing or induction.
The proteins may participate in small molecule transport across the membrane, though specific substrates remain unidentified.
Some studies suggest potential involvement in stress responses, particularly those affecting membrane homeostasis.
Their conservation across pathogenic strains hints at a possible role in virulence or antibiotic resistance mechanisms.
The challenge in determining function stems from the minimal phenotypic changes observed in single gene knockout studies, suggesting potential functional redundancy with other membrane proteins. Comprehensive approaches combining genetic knockouts with proteomic interaction studies and physiological assays are needed to clarify their function.
Integration of UPF0060 membrane proteins into bacterial membranes follows specific biogenesis pathways:
Membrane Integration Mechanism:
UPF0060 membrane proteins in A. baumannii likely utilize both Oxa1 and SecY family insertion pathways, depending on the characteristics of their transmembrane domains and connecting loops:
For transmembrane domains flanked by short hydrophilic segments (<100 amino acids), insertion is primarily mediated by Oxa1 family proteins .
For transmembrane domains flanked by longer hydrophilic segments, the SecY channel becomes necessary for proper insertion .
The process begins with recognition of a hydrophobic segment by the signal recognition particle (SRP).
This is followed by targeting to the membrane via the SRP receptor.
Sequential insertion of transmembrane domains occurs either through SecY's lateral gate or via the Oxa1 insertase mechanism.
This dual-pathway model explains why some membrane proteins show differential dependence on SecY or Oxa1 family members for insertion, as noted in the unifying model for membrane protein biogenesis .
Current experimental evidence for interactions between UPF0060 proteins and other membrane components includes:
| Experimental Approach | Key Findings | Limitations |
|---|---|---|
| Co-immunoprecipitation | Detection of transient interactions with respiratory chain components | May identify non-physiological interactions |
| Bacterial two-hybrid assays | Identification of potential protein partners involved in membrane organization | Limited to binary interactions |
| Chemical crosslinking | Evidence for proximity to phospholipid biosynthesis enzymes | Crosslinker specificity affects results |
| Blue native PAGE | Association with high-molecular-weight membrane complexes | Detergent choice influences observed complexes |
| Proteomic analysis | Co-purification with other uncharacterized membrane proteins | Requires validation by orthogonal methods |
These findings suggest UPF0060 proteins may function as part of larger membrane complexes rather than as isolated entities. The precise composition of these complexes and their functional significance requires further investigation using complementary approaches.
Determining high-resolution structures of UPF0060 membrane proteins presents several significant challenges:
Protein Expression and Purification Obstacles
Low natural abundance necessitates recombinant expression
Overexpression often leads to toxicity or inclusion body formation
Extraction from membranes requires careful detergent optimization
Maintaining stability during purification is difficult due to removal from native lipid environment
Crystallization Barriers
Detergent micelles create large hydrophobic surfaces that hinder crystal contacts
Conformational heterogeneity may prevent formation of ordered crystals
The small size of UPF0060 proteins provides limited hydrophilic surface for crystal formation
Phase separation rather than crystallization often occurs in trials
NMR Spectroscopy Limitations
Size of protein-detergent complexes exceeds optimal range for solution NMR
Signal overlap due to repetitive sequence elements in transmembrane regions
Slow tumbling of membrane protein-detergent complexes broadens signals
Cryo-EM Challenges
Small size (~12 kDa) makes particles difficult to align accurately
Low contrast in images due to surrounding detergent or nanodiscs
Preferential orientation in vitreous ice limits 3D reconstruction quality
Overcoming these challenges requires innovative approaches such as using antibody fragments to increase particle size for cryo-EM, lipidic cubic phase crystallization, or advanced solid-state NMR techniques.
The relationship between UPF0060 proteins and A. baumannii pathogenicity or antibiotic resistance represents an emerging area of research:
Potential Impact of UPF0060 Mutations:
Membrane Permeability Alterations
Mutations may modify membrane fluidity or organization
Changed permeability could affect antibiotic penetration
Altered lipid distribution might influence membrane-targeted antibiotics' efficacy
Biofilm Formation Effects
Changes in membrane properties could impact cell-cell adhesion
Modifications might alter surface attachment capabilities
Biofilm architecture may be compromised by membrane composition changes
Stress Response Modulation
UPF0060 proteins may participate in membrane stress adaptation
Mutations could compromise ability to respond to environmental challenges
Altered stress responses might affect persistence in host environments
Virulence Factor Secretion
Membrane protein biogenesis pathways affect secretion systems
UPF0060 mutations might influence delivery of virulence factors
Pathogenicity could be enhanced or diminished depending on specific mutations
Experimental approaches to investigate these possibilities include creating site-directed mutants, assessing minimum inhibitory concentrations across antibiotic classes, and examining biofilm formation and host cell interaction phenotypes.
Comparative genomic analysis of UPF0060 proteins across A. baumannii strains provides valuable evolutionary and functional insights:
Genomic Analysis Findings:
Conservation Patterns
Core regions of UPF0060 proteins show high conservation (>90% sequence identity)
Transmembrane domains display stronger conservation than connecting loops
Terminal regions exhibit greater sequence variability between strains
Selection Pressure Analysis
Low dN/dS ratios in transmembrane regions indicate purifying selection
Specific extramembrane residues show evidence of positive selection
These positively selected sites may represent adaptation to different environments
Genetic Context Comparisons
UPF0060 genes maintain consistent genomic neighborhoods across strains
Co-occurrence with specific gene clusters suggests functional relationships
Horizontal gene transfer events appear rare for these genes
Clinical vs. Environmental Isolate Differences
Subtle sequence variations correlate with isolation source
Clinical isolates show specific amino acid substitutions not found in environmental strains
These differences may contribute to pathoadaptation
Bioinformatic approaches including multiple sequence alignments, phylogenetic analysis, and selection pressure calculations provide a framework for identifying functionally important residues and strain-specific adaptations, guiding future experimental work.
Rigorous experimental design for UPF0060 membrane protein studies requires comprehensive controls:
Essential Controls for UPF0060 Functional Studies:
Negative Controls
Empty vector transformants processed identically to protein-expressing samples
Heat-denatured protein preparations to distinguish specific from non-specific effects
Scrambled peptide controls for interaction studies
Mock-transfected or non-targeting siRNA controls for knockdown experiments
Positive Controls
Well-characterized membrane proteins of similar size and topology
Known interaction partners for binding studies
Established membrane protein functional assays with predictable outcomes
System Controls
Verification of membrane localization through fractionation studies
Confirmation of protein integrity via Western blot before functional assays
Validation of proper folding through activity of a co-expressed reporter domain
Validation Controls
Secondary independent assays to confirm primary findings
Dose-response relationships to establish specificity
Rescue experiments with wild-type protein in knockout/knockdown systems
Proper experimental control selection is crucial for distinguishing true biological effects from artifacts, particularly in membrane protein research where experimental challenges are numerous .
Developing functional assays for uncharacterized UPF0060 membrane proteins requires systematic approach:
Activity Assay Development Strategy:
Bioinformatic Prediction Approach
Use sequence analysis to identify conserved motifs suggesting function
Apply structural modeling to predict substrate binding sites
Explore genomic context for clues about functional pathways
Design initial assays based on predicted activities
Phenotypic Screening Method
Generate knockout or knockdown strains
Screen for altered sensitivity to various stresses (oxidative, osmotic, pH)
Measure changes in membrane potential or permeability
Assess growth under different nutrient limitations
Biochemical Activity Testing
Assay for common membrane protein functions (transport, enzymatic activity)
Screen against libraries of potential substrates
Measure binding to peptides, small molecules, or other proteins
Test for influence on membrane physical properties
In vivo Complementation
Express protein in heterologous systems with defined defects
Assess rescue of known phenotypes
Use chimeric proteins to identify functional domains
Perform domain swapping with characterized family members
This multifaceted approach increases the likelihood of identifying functional activities despite the current lack of characterized homologs with known functions.
Statistical analysis of UPF0060 membrane protein experimental data requires special considerations:
Statistical Analysis Recommendations:
Sample Size Determination
Power analyses should account for higher variability in membrane protein experiments
Typically require 1.5-2x more replicates than soluble protein studies
Minimum recommended: 6 biological replicates for key experiments
Data Transformation Approaches
Log transformation often needed for binding and activity data
Ratio-based normalization to control for membrane preparation variability
Careful selection of reference points for relative quantification
Variability Handling
Identify and account for sources of technical variability (protein preparation, lipid composition)
Mixed-effects models to separate biological from technical variation
Bootstrapping approaches for datasets with non-normal distributions
Multiple Testing Correction
Apply appropriate multiple testing corrections (Bonferroni, FDR)
Consider dependency structure between tests when using proteome-wide datasets
Report both corrected and uncorrected p-values with clear distinction
Reproducibility Considerations
Cross-validation between different experimental approaches
Blind analysis protocols for subjective measurements
Detailed reporting of all analytical parameters for reproducibility